Terms: = Head and neck cancer AND KMT2D, ENSG00000167548, 8085, MLL2 AND Prognosis
13 results:
1. Identification of Somatic Mutations in Plasma Cell-Free DNA from Patients with Metastatic Oral Squamous Cell Carcinoma.
Lin LH; Chang KW; Cheng HW; Liu CJ
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373553
[TBL] [Abstract] [Full Text] [Related]
2. CDK12 alterations and ARID1A mutations are predictors of poor prognosis and therapeutic targets in high-grade salivary gland carcinoma: analysis of the National Genomic Profiling Database.
Kobayashi K; Saito Y; Kage H; Fukuoka O; Yamamura K; Mukai T; Oda K; Yamasoba T
Jpn J Clin Oncol; 2023 Aug; 53(9):798-807. PubMed ID: 37357968
[TBL] [Abstract] [Full Text] [Related]
3. Construction and Validation of an Immune-Related Gene Prognostic Index for Esophageal Squamous Cell Carcinoma.
Ji Q; Cai Y; Shrestha SM; Shen D; Zhao W; Shi R
Biomed Res Int; 2021; 2021():7430315. PubMed ID: 34722771
[TBL] [Abstract] [Full Text] [Related]
4. CYLD mutation characterizes a subset of HPV-positive head and neck squamous cell carcinomas with distinctive genomics and frequent cylindroma-like histologic features.
Williams EA; Montesion M; Alexander BM; Ramkissoon SH; Elvin JA; Ross JS; Williams KJ; Glomski K; Bledsoe JR; Tse JY; Mochel MC
Mod Pathol; 2021 Feb; 34(2):358-370. PubMed ID: 32892208
[TBL] [Abstract] [Full Text] [Related]
5. Tumor-infiltrating lymphocyte-derived mll2 independently predicts disease-free survival for patients with early-stage oral squamous cell carcinoma.
Zhu N; Ding L; Fu Y; Yang Y; Chen S; Chen W; Zhao M; Zhao X; Lu Z; Ni Y; Hu Q
J Oral Pathol Med; 2020 Feb; 49(2):126-136. PubMed ID: 31660637
[TBL] [Abstract] [Full Text] [Related]
6. Oncoproteomic and gene expression analyses identify prognostic biomarkers for second primary malignancy in patients with head and neck squamous cell carcinoma.
Bunbanjerdsuk S; Vorasan N; Saethang T; Pongrujikorn T; Pangpunyakulchai D; Mongkonsiri N; Arsa L; Thokanit N; Pongsapich W; Anekpuritanang T; Ngamphaiboon N; Jinawath A; Sunpaweravong S; Pisitkun T; Suktitipat B; Jinawath N
Mod Pathol; 2019 Jul; 32(7):943-956. PubMed ID: 30737471
[TBL] [Abstract] [Full Text] [Related]
7. Intratumoral heterogeneity of esophageal squamous cell carcinoma and its clinical significance.
Wang X; Jia Y; Deng H; Liu Y; Liu Y
Pathol Res Pract; 2019 Feb; 215(2):308-314. PubMed ID: 30528923
[TBL] [Abstract] [Full Text] [Related]
8. Improved outcomes in PI3K-pathway-altered metastatic HPV oropharyngeal cancer.
Hanna GJ; Kacew A; Chau NG; Shivdasani P; Lorch JH; Uppaluri R; Haddad RI; MacConaill LE
JCI Insight; 2018 Sep; 3(17):. PubMed ID: 30185662
[TBL] [Abstract] [Full Text] [Related]
9. Does smoking alter the mutation profile of human papillomavirus-driven head and neck cancers?
Mirghani H; Lacroix L; Rossoni C; Sun R; Aupérin A; Casiraghi O; Villepelet A; Lacave R; Faucher G; Marty V; Ferté C; Soria JC; Even C
Eur J Cancer; 2018 May; 94():61-69. PubMed ID: 29533868
[TBL] [Abstract] [Full Text] [Related]
10. High mll2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract] [Full Text] [Related]
11. Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function.
Choi M; Kadara H; Zhang J; Parra ER; Rodriguez-Canales J; Gaffney SG; Zhao Z; Behrens C; Fujimoto J; Chow C; Kim K; Kalhor N; Moran C; Rimm D; Swisher S; Gibbons DL; Heymach J; Kaftan E; Townsend JP; Lynch TJ; Schlessinger J; Lee J; Lifton RP; Herbst RS; Wistuba II
Ann Oncol; 2017 Jan; 28(1):83-89. PubMed ID: 28177435
[TBL] [Abstract] [Full Text] [Related]
12. Genomic Alterations of Anaplastic Thyroid Carcinoma Detected by Targeted Massive Parallel Sequencing in a BRAF(V600E) Mutation-Prevalent Area.
Jeon MJ; Chun SM; Kim D; Kwon H; Jang EK; Kim TY; Kim WB; Shong YK; Jang SJ; Song DE; Kim WG
Thyroid; 2016 May; 26(5):683-90. PubMed ID: 26980298
[TBL] [Abstract] [Full Text] [Related]
13. Follicular cell-derived thyroid cancer.
Dralle H; Machens A; Basa J; Fatourechi V; Franceschi S; Hay ID; Nikiforov YE; Pacini F; Pasieka JL; Sherman SI
Nat Rev Dis Primers; 2015 Dec; 1():15077. PubMed ID: 27188261
[TBL] [Abstract] [Full Text] [Related]
